Related Experiment Video
Updated: Apr 23, 2026

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
Published on: March 1, 2019
Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia
Katie N Murray1, Sylvie Girard1, William M Holmes1
1From the Faculty of Life Sciences (K.N.M., S.M.A.) and Centre for Imaging Science (L.M.P., S.R.W.), University of Manchester, Manchester, United Kingdom; Sainte-Justine Hospital Research Centre, University of Montreal, Canada (S.G.); Glasgow Experimental MRI Centre, The University of Glasgow, Glasgow, United Kingdom (W.M.H.); and University of Manchester, Manchester Academic Health Sciences Centre, United Kingdom (A.R.P.-J.).
Background And Purpose:
Systemic inflammation contributes to diverse acute and chronic brain pathologies, and extensive evidence implicates inflammation in stroke susceptibility and poor outcome. Here we investigate whether systemic inflammation alters cerebral blood flow during reperfusion after experimental cerebral ischemia.
Methods:
Serial diffusion and perfusion-weighted MRI was performed after reperfusion in Wistar rats given systemic (intraperitoneal) interleukin-1β or vehicle before 60-minute transient middle cerebral artery occlusion. The expression and location of endothelin-1 was assessed by polymerase chain reaction, ELISA, and immunofluorescence.
Results:
Systemic interleukin-1 caused a severe reduction in cerebral blood flow and increase in infarct volume compared with vehicle. Restriction in cerebral blood flow was observed alongside activation of the cerebral vasculature and upregulation of the vasoconstricting peptide endothelin-1 in the ischemic penumbra. A microthrombotic profile was also observed in the vasculature of rats receiving interleukin-1. Blockade of endothelin-1 receptors reversed this hypoperfusion, reduced tissue damage, and improved functional outcome.
Conclusions:
These data suggest patients with a raised inflammatory profile may have persistent deficits in perfusion after reopening of an occluded vessel. Future therapeutic strategies to interrupt the mechanism identified could lead to enhanced recovery of penumbra in patients with a heightened inflammatory burden and a better outcome after stroke.
Insights
Systemic inflammation, triggered by interleukin-1, severely reduces cerebral blood flow and worsens stroke outcomes in rats. Blocking endothelin-1 receptors improved blood flow and reduced brain damage, suggesting a therapeutic target for stroke recovery.
Area of Science:
- Neuroscience
- Immunology
- Cardiovascular Research
Background:
- Systemic inflammation is linked to brain pathologies and poor stroke outcomes.
- Interleukin-1 (IL-1) plays a significant role in inflammatory responses.
- Cerebral blood flow regulation during reperfusion is critical for stroke recovery.
Purpose of the Study:
- To investigate the impact of systemic inflammation on cerebral blood flow during reperfusion after experimental cerebral ischemia.
- To explore the role of endothelin-1 in mediating inflammatory effects on cerebral perfusion.
Main Methods:
- Wistar rats underwent transient middle cerebral artery occlusion followed by reperfusion.
- Systemic interleukin-1β or vehicle was administered intraperitoneally.
- Cerebral blood flow was assessed using diffusion and perfusion-weighted MRI.
- Endothelin-1 expression and location were analyzed via PCR, ELISA, and immunofluorescence.
Main Results:
- Systemic IL-1 significantly reduced cerebral blood flow and increased infarct volume compared to controls.
- Cerebral hypoperfusion correlated with activated cerebral vasculature and upregulated endothelin-1 in the ischemic penumbra.
- Microthrombi were observed in the vasculature of IL-1 treated rats.
- Endothelin-1 receptor blockade reversed hypoperfusion, reduced tissue damage, and improved functional outcomes.
Conclusions:
- Systemic inflammation, particularly via IL-1, impairs cerebral blood flow during reperfusion.
- Endothelin-1 is a key mediator of this inflammatory-induced hypoperfusion.
- Targeting endothelin-1 pathways may offer therapeutic benefits for stroke patients with elevated inflammatory profiles.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Acute Inflammation II: Local and Systemic Effects
Ischemic Stroke l: Introduction
Cerebral Edema ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Transient Ischemic Attack l: Introduction

